Page 129 - NobleCon20-Book-Project

Ocugen, Inc.

SELECTED FINANCIAL ITEMS OCGN

(in millions of USD)
CQ4 '23 CQ1 '24 CQ2 '24 CQ3 '24 LTM
Income Statement Key Items
Total Revenue 6.04 1.01 1.14 1.14 9.33
Gross Profit (3.47) (5.81) (7.76) (6.97) (24.01)
Gross Margin -57% -573% -680% -614% -257%
EBIT (8.62) (12.22) (15.45) (13.25) (49.54)
EBIT Margin -143% -1205% -1354% -1167% -531%
Net Income to Common Shareholders (9.49) (11.92) (15.28) (12.97) (49.67)
Net Margin -157% -1176% -1339% -1142% -533%

Balance Sheet Key Items
Total Assets 64.55 51.79 40.54 61.94 61.94
Cash & Short Term Investments 39.46 26.38 15.70 38.70 38.70
% of Assets 61% 51% 39% 62% 62%
Current Assets -Total 42.97 30.00 18.62 40.67 40.67
% of Assets 67% 58% 46% 66% 66%
Total Liabilities 23.98 21.53 23.62 21.31 21.31
% of Assets 37% 42% 58% 34% 34%
Current Liabilities - Total 17.09 16.05 17.97 15.76 15.76
% of Assets 26% 31% 44% 25% 25%
Long Term Debt 2.80 1.53 1.55 1.57 1.57
% of Assets 4% 3% 4% 3% 3%
Total Equity 40.56 30.26 16.93 40.63 40.63
% of Assets 63% 58% 42% 66% 66%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (11.30) (10.60) (9.91) (11.27) (43.08)
Net Cash Flow - Investing (2.72) (2.35) (0.51) (0.51) (6.09)
Net Cash Flow - Financing 0.02 (0.15) 0.05 34.79 34.70

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Twentieth Annual Small & Microcap Investor Conference